Detection of Pro- and Antiangiogenic Factors in the Human Sclera

References

• Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3(11):879–89. doi:10.1038/nri1224.
   PubMed Web of Science ®Google Scholar
• Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol. 2003;74(2):179–85. doi:10.1189/jlb.1102574.
   PubMed Web of Science ®Google Scholar
• Cursiefen C. Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy. 2007;92:50–57.
   PubMedGoogle Scholar
• Cursiefen C, Cao J, Chen L, Liu Y, Maruyama K, Jackson D, Kruse FE, Wiegand SJ, Dana MR, Streilein JW. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45:2666–73.
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Masli S, Ng TF, Dana MR, Bornstein P, Lawler J, Streilein JW. Roles of thrombospondin-1 and −2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci. 2004;45:1117–24.
   PubMed Web of Science ®Google Scholar
• Chen L, Hamrah P, Cursiefen C, Zhang Q, Pytowski B, Streilein JW, Dana MR. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med. 2004;10:813–15.
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S, Pytowski B, Persaud K, Wu Y, Streilein JW, et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A. 2006;103(30):11405–10.
   PubMed Web of Science ®Google Scholar
• Foster CS, Sainz de la Maza M. The sclera. 2012. p. 14–23. NewYork, NY: Springer-Verlag.
   Google Scholar
• Schlereth SL, Neuser B, Herwig MC, Muller AM, Koch KR, Reitsamer HA, Schrodl F, Cursiefen C, Heindl LM. Absence of lymphatic vessels in the developing human sclera. Exp Eye Res. 2014;125:203–09.
   PubMed Web of Science ®Google Scholar
• Schlereth SL, Neuser B, Caramoy A, Grajewski RS, Koch KR, Schrodl F, Cursiefen C, Heindl LM. Enrichment of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1)-positive macrophages around blood vessels in the normal human sclera. Invest Ophthalmol Vis Sci. 2014;55(2):865–72. doi:10.1167/iovs.13-13453.
   PubMed Web of Science ®Google Scholar
• Herwig MC, Munstermann K, Klarmann-Schulz U, Schlereth SL, Heindl LM, Loeffler KU, Muller AM. Expression of the lymphatic marker podoplanin (D2-40) in human fetal eyes. Exp Eye Res. 2014;127:243–51. doi:10.1016/j.exer.2014.07.026.
   PubMed Web of Science ®Google Scholar
• Hos D, Schlereth SL, Bock F, Heindl LM, Cursiefen C. Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye? Semin Cell Dev Biol. 2014;38:117–130.
   PubMed Web of Science ®Google Scholar
• Streilein JW, Yamada J, Dana MR, Ksander BR. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc. 1999;31(3):1472–75. doi:10.1016/S0041-1345(99)00010-X.
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Schlotzer-Schrehardt U, Kuchle M, Sorokin L, Breiteneder-Geleff S, Alitalo K, Jackson D. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci. 2002;43:2127–35.
   PubMed Web of Science ®Google Scholar
• Reuer TS, Schneider AC, Cakir B, Bühler AD, Walz JM, Lapp T, Lange C, Agostini H, Schlunck G, Cursiefen C, et al. Semaphorin 3F modulates corneal lymphangiogenesis and promotes corneal graft survival. Invest Ophthalmol Vis Sci. 2018. in press.
   PubMed Web of Science ®Google Scholar
• Gausas RE, Gonnering RS, Lemke BN, Dortzbach RK, Sherman DD. Identification of human orbital lymphatics. Ophthal Plast Reconstr Surg. 1999;15(4):252–59. doi:10.1097/00002341-199907000-00006.
   PubMed Web of Science ®Google Scholar
• Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology. 2011;118(12):2351–60. doi:10.1016/j.ophtha.2011.05.025.
   PubMed Web of Science ®Google Scholar
• Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Tumor-associated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci. 2011;52(10):7074–83. doi:10.1167/iovs.11-7902.
   PubMed Web of Science ®Google Scholar
• Heindl LM, Hofmann-Rummelt C, Adler W, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology. 2010;117(4):649–58. doi:10.1016/j.ophtha.2010.01.032.
   PubMed Web of Science ®Google Scholar
• Schroedl F, Kaser-Eichberger A, Schlereth SL, Bock F, Regenfuss B, Reitsamer HA, Lutty GA, Maruyama K, Chen L, Lutjen-Drecoll E, et al. Consensus statement on the immunohistochemical detection of ocular lymphatic vessels. Invest Ophthalmol Vis Sci. 2014;55(10):6440–42. doi:10.1167/iovs.14-15638.
   PubMed Web of Science ®Google Scholar
• Heindl LM, Hofmann TN, Knorr HL, Rummelt C, Schrodl F, Schlotzer-Schrehardt U, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci. 2009;50(5):1988–95. doi:10.1167/iovs.08-2935.
   PubMed Web of Science ®Google Scholar
• Regenfuss B, Dreisow ML, Hos D, Masli S, Bock F, Cursiefen C. The naive murine cornea as a model system to identify novel endogenous regulators of lymphangiogenesis: TRAIL and rtPA. Lymphat Res Biol. 2015;13(2):76–84. doi:10.1089/lrb.2015.0004.
   PubMed Web of Science ®Google Scholar
• Regenfuss B, Onderka J, Bock F, Hos D, Maruyama K, Cursiefen C. Genetic heterogeneity of lymphangiogenesis in different mouse strains. Am J Pathol. 2010;177(1):501–10. doi:10.2353/ajpath.2010.090794.
   PubMed Web of Science ®Google Scholar
• Bock F, Maruyama K, Regenfuss B, Hos D, Steven P, Heindl LM, Cursiefen C. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Prog Retin Eye Res. 2013;34:89–124. doi:10.1016/j.preteyeres.2013.01.001.
   PubMed Web of Science ®Google Scholar
• Rohan RM, Fernandez A, Udagawa T, Yuan J, D’Amato RJ. Genetic heterogeneity of angiogenesis in mice. FASEB J. 2000;14(7):871–76. doi:10.1096/fasebj.14.7.871.
   PubMed Web of Science ®Google Scholar
• Iruela-Arispe ML, Carpizo D, Luque A. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci. 2003;995:183–90.
   PubMed Web of Science ®Google Scholar
• Dai X, She P, Chi F, Feng Y, Liu H, Jin D, Zhao Y, Guo X, Jiang D, Guan KL, et al. Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis. J Biol Chem. 2013;288(47):34041–51.
   PubMed Web of Science ®Google Scholar
• Lv M, Lv M, Chen L, Qin T, Zhang X, Liu P, Yang J. Angiomotin promotes breast cancer cell proliferation and invasion. Oncol Rep. 2015;33:1938–46.
   PubMed Web of Science ®Google Scholar
• Li S, Hu GF. Emerging role of angiogenin in stress response and cell survival under adverse conditions. J Cell Physiol. 2012;227:2822–26.
   PubMed Web of Science ®Google Scholar
• Thurston G. Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res. 2003;314:61–68.
   PubMed Web of Science ®Google Scholar
• Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277(5322):55–60.
   PubMed Web of Science ®Google Scholar
• Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, Bartol A, Kienast Y, Vettel C, Loos EK, et al. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest. 2012;122(6):1991–2005.
   PubMed Web of Science ®Google Scholar
• Kim I, Moon SO, Koh KN, Kim H, Uhm CS, Kwak HJ, Kim NG, Koh GY. Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem. 1999;274:26523–28.
   PubMed Web of Science ®Google Scholar
• Mathema VB, Na-Bangchang K. Regulatory roles of brain-specific angiogenesis inhibitor 1(BAI1) protein in inflammation, tumorigenesis and phagocytosis: A brief review. Crit Rev Oncol Hematol. 2017;111:81–86.
   PubMed Web of Science ®Google Scholar
• Park D, Kim Y, Kim H, Kim K, Lee YS, Choe J, Hahn JH, Lee H, Jeon J, Choi C, et al. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFbeta receptor interaction via CD44-PKCdelta. Mol Cells. 2012;33(6):563–74.
   PubMed Web of Science ®Google Scholar
• Gerstel D, Wegwitz F, Jannasch K, Ludewig P, Scheike K, Alves F, Beauchemin N, Deppert W, Wagener C, Horst AK. CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. Oncogene. 2011;30:4275–88.
   PubMed Web of Science ®Google Scholar
• Marneros AG, Olsen BR. The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol. 2001;20:337–45.
   PubMed Web of Science ®Google Scholar
• Galambos C, Minic AD, Bush D, Nguyen D, Dodson B, Seedorf G, Abman SH. Increased lung expression of anti-angiogenic factors in down syndrome: potential role in abnormal lung vascular growth and the risk for pulmonary hypertension. PLoS One. 2016;11:e0159005.
   PubMed Web of Science ®Google Scholar
• Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci U S A. 2003;100:4766–71.
   PubMed Web of Science ®Google Scholar
• Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003;3:422–33.
   PubMed Web of Science ®Google Scholar
• Zins SR, Amare MF, Tadaki DK, Elster EA, Davis TA. Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy. Angiogenesis. 2010;13:293–304.
   PubMed Web of Science ®Google Scholar
• Lee MS, Ghim J, Kim SJ, Yun YS, Yoo SA, Suh PG, Kim WU, Ryu SH. Functional interaction between CTGF and FPRL1 regulates VEGF-A-induced angiogenesis. Cell Signal. 2015;27:1439–48.
   PubMed Web of Science ®Google Scholar
• Murphy K, Travers P, Walport M. Janeway´s Immunobiology; 2008. New York, US: Garland Science, Taylor & Francis Group.
   Google Scholar
• Zheng H, Fu G, Dai T, Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol. 2007;50:274–80.
   PubMed Web of Science ®Google Scholar
• Niu X, Chang W, Liu R, Hou R, Li J, Wang C, Li X, Zhang K. mRNA and protein expression of the angiogenesis-related genes EDIL3, AMOT and ECM1 in mesenchymal stem cells in psoriatic dermis. Clin Exp Dermatol. 2016;41:533–40.
   PubMed Web of Science ®Google Scholar
• Berardi AC, Marsilio S, Rofani C, Salvucci O, Altavista P, Perla FM, Diomedi-Camassei F, Uccini S, Kokai G, Landuzzi L, et al. Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma. Anticancer Res. 2008;28(2A):763–69.
   PubMed Web of Science ®Google Scholar
• Albig AR, Neil JR, Schiemann WP. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res. 2006;66:2621–29.
   PubMed Web of Science ®Google Scholar
• Bai Y, Leng Y, Yin G, Pu X, Huang Z, Liao X, Chen X, Yao Y. Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo. Cell Tissue Res. 2014;356:109–21.
   PubMed Web of Science ®Google Scholar
• Marconcini L, Marchio S, Morbidelli L, Cartocci E, Albini A, Ziche M, Bussolino F, Oliviero S. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci U S A. 1999;96:9671–76.
   PubMed Web of Science ®Google Scholar
• Chappell JC, Mouillesseaux KP, Bautch VL. Flt-1 (vascular endothelial growth factor receptor-1) is essential for the vascular endothelial growth factor-Notch feedback loop during angiogenesis. Arterioscler Thromb Vasc Biol. 2013;33:1952–59.
   PubMed Web of Science ®Google Scholar
• Weijts BG, van Impel A, Schulte-Merker S, de Bruin A. Atypical E2fs control lymphangiogenesis through transcriptional regulation of Ccbe1 and Flt4. PLoS One. 2013;8:e73693.
   PubMed Web of Science ®Google Scholar
• Chiu CH, Chou CW, Takada S, Liu YW. Development and fibronectin signaling requirements of the zebrafish interrenal vessel. PLoS One. 2012;7:e43040.
   PubMed Web of Science ®Google Scholar
• Shi L, Resaul J, Owen S, Ye L, Jiang WG. Clinical and therapeutic implications of follistatin in solid tumours. Cancer Genomics Proteomics. 2016;13:425–35.
   PubMed Web of Science ®Google Scholar
• Sanders AJ, Ye L, Li J, Mason MD, Jiang WG. Tumour angiogenesis and repulsive guidance molecule b: a role in HGF- and BMP-7-mediated angiogenesis. Int J Oncol. 2014;45:1304–12.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Wang J, Cao R, Morita H, Soininen R, Chan KM, Liu B, Cao Y, Tryggvason K. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res. 2004;64:4699–702.
   PubMed Web of Science ®Google Scholar
• Rosenberg EE, Prudnikova TY, Zabarovsky ER, Kashuba VI, Grigorieva EV. D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells. Tumour Biol. 2014;35:3237–45.
   PubMedGoogle Scholar
• Ashkar AA, Croy BA. Interferon-gamma contributes to the normalcy of murine pregnancy. Biol Reprod. 1999;61:493–502.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yoshida S, Kubo Y, Kobayashi Y, Nakama T, Yamaguchi M, Ishikawa K, Nakao S, Ikeda Y, Ishibashi T, et al. Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy. Sci Rep. 2016;6:28140.
   PubMed Web of Science ®Google Scholar
• Ruegg C, Dormond O, Foletti A. Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target? Endothelium. 2002;9:151–60.
   PubMed Web of Science ®Google Scholar
• Li TS, Hamano K, Nishida M, Hayashi M, Ito H, Mikamo A, Matsuzaki M. CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol. 2003;285:H931–7.
   PubMed Web of Science ®Google Scholar
• Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. Embo J. 1987;6:3341–51.
   PubMed Web of Science ®Google Scholar
• Sun X, Wei J, Tang Y, Wang B, Zhang Y, Shi L, Guo J, Hu F, Li X. Leptin-induced migration and angiogenesis in rheumatoid arthritis is mediated by reactive oxygen species. FEBS Open Bio. 2017;7:1899–908.
   PubMed Web of Science ®Google Scholar
• Kang DY, Sp N, Kim DH, Joung YH, Lee HG, Park YM, Yang YM. Salidroside inhibits migration, invasion and angiogenesis of MDAMB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2. Int J Oncol. 2018;56(2):877–885.
   Web of Science ®Google Scholar
• Shimizu A, Zankov DP, Kurokawa-Seo M, Ogita H. Vascular endothelial growth Factor-A exerts diverse cellular effects via small G Proteins, Rho and Rap. Int J Mol Sci. 2018;19(4):1203.
   Web of Science ®Google Scholar
• Lin B, Song X, Yang D, Bai D, Yao Y, Lu N. Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRbeta and FGFR1. Gene. 2018;654:77–86.
   PubMed Web of Science ®Google Scholar
• Didiasova M, Wujak L, Wygrecka M, Zakrzewicz D. From plasminogen to plasmin: role of plasminogen receptors in human cancer. Int J Mol Sci. 2014;15:21229–52.
   PubMed Web of Science ®Google Scholar
• LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature. 2001;412(6850):877–84.
   PubMed Web of Science ®Google Scholar
• Monnier J, Samson M. Prokineticins in angiogenesis and cancer. Cancer Lett. 2010;296:144–49.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang Y, Wang S, Dong QZ, Shen Z, Wang W, Tao S, Gu C, Liu J, Xie Y, et al. Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression. Hepatology. 2017;66(6):1894–909.
   PubMed Web of Science ®Google Scholar
• Papadimitriou E, Pantazaka E, Castana P, Tsalios T, Polyzos A, Beis D. Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer. Biochim Biophys Acta. 2016;1866:252–65.
   PubMed Web of Science ®Google Scholar
• Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J, et al. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res. 2009;15(22):6763–70.
   PubMed Web of Science ®Google Scholar
• Bodenstine TM, Seftor RE, Khalkhali-Ellis Z, Seftor EA, Pemberton PA, Hendrix MJ. Maspin: molecular mechanisms and therapeutic implications. Cancer Metastasis Rev. 2012;31:529–51.
   PubMed Web of Science ®Google Scholar
• Xu B, Li J, Liu X, Li C, Chang X. TXNDC5 is a cervical tumor susceptibility gene that stimulates cell migration, vasculogenic mimicry and angiogenesis by down-regulating SERPINF1 and TRAF1 expression. Oncotarget. 2017;8:91009–24.
   PubMedGoogle Scholar
• Ferrari G, Cook BD, Terushkin V, Pintucci G, Mignatti P. Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol. 2009;219:449–58.
   PubMed Web of Science ®Google Scholar
• Bornstein P. Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal. 2009;3:189–200.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson WG, Seo DW. TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol Med. 2005;11:97–103.
   PubMed Web of Science ®Google Scholar
• Metheny-Barlow LJ, Li LY. Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis. Semin Ophthalmol. 2006;21:49–58.
   PubMedGoogle Scholar
• Kimura H, Miyashita H, Suzuki Y, Kobayashi M, Watanabe K, Sonoda H, Ohta H, Fujiwara T, Shimosegawa T, Sato Y. Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood. 2009;113(19):4810–18. doi:10.1182/blood-2008-07-170316.
   PubMed Web of Science ®Google Scholar
• Udan RS, Culver JC, Dickinson ME. Understanding vascular development. Wiley Interdiscip Rev Dev Biol. 2013;2(3):327–46. doi:10.1002/wdev.91.
   PubMed Web of Science ®Google Scholar
• Chien MH, Ku CC, Johansson G, Chen MW, Hsiao M, Su JL, Inoue H, Hua KT, Wei LH, Kuo ML. Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway. Carcinogenesis. 2009;30(12):2005–13. doi:10.1093/carcin/bgp244.
   PubMed Web of Science ®Google Scholar
• Harrison SA, Mondino BJ, Mayer FJ. Scleral fibroblasts. Human leukocyte antigen expression and complement production. Invest Ophthalmol Vis Sci. 1990;31:2412–19.
   PubMed Web of Science ®Google Scholar
• Stevenson W, Cheng SF, Dastjerdi MH, Ferrari G, Dana R. Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf. 2012;10(2):67–83. doi:10.1016/j.jtos.2012.01.005.
   PubMed Web of Science ®Google Scholar
• Ferrari G, Dastjerdi MH, Okanobo A, Cheng SF, Amparo F, Nallasamy N, Dana R. Topical ranibizumab as a treatment of corneal neovascularization. Cornea. 2013;32(7):992–97. doi:10.1097/ICO.0b013e3182775f8d.
   PubMed Web of Science ®Google Scholar
• Jiang S, Park C, Barner JC. Ranibizumab for age-related macular degeneration: a meta-analysis of dose effects and comparison with no anti-VEGF treatment and bevacizumab. J Clin Pharm Ther. 2014;39(3):234–39. doi:10.1111/jcpt.2014.39.issue-3.
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Viaud E, Bock F, Geudelin B, Ferry A, Kadlecova P, Levy M, Al Mahmood S, Colin S, Thorin E, et al. Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study. Ophthalmology. 2014;121(9):1683–92. doi:10.1016/j.ophtha.2014.03.038.
   PubMed Web of Science ®Google Scholar
• Ardeljan D, Meyerle CB, Agron E, Wang JJ, Mitchell P, Chew EY, Zhao J, Maminishkis A, Chan CC, Tuo J. Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration. Eur J Hum Genet. 2013;21(10):1152–57. doi:10.1038/ejhg.2013.14.
   PubMed Web of Science ®Google Scholar
• Aparicio S, Sawant S, Lara N, Barnstable CJ, Tombran-Tink J. Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF. Biochem Biophys Res Commun. 2005;326(2):387–94. doi:10.1016/j.bbrc.2004.11.041.
   PubMed Web of Science ®Google Scholar
• Rychli K, Kaun C, Hohensinner PJ, Dorfner AJ, Pfaffenberger S, Niessner A, Bauer M, Dietl W, Podesser BK, Maurer G, et al. The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts. J Cell Mol Med. 2010;14(1–2):198–205. doi:10.1111/j.1582-4934.2009.00731.x.
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2003;44(10):4473–80. doi:10.1167/iovs.02-1115.
   PubMed Web of Science ®Google Scholar
• Evans NJ, Brown JM, Scholey R, Murray RD, Birtles RJ, Hart CA, Carter SD. Differential inflammatory responses of bovine foot skin fibroblasts and keratinocytes to digital dermatitis treponemes. Vet Immunol Immunopathol. 2014;161(1–2):12–20. doi:10.1016/j.vetimm.2014.05.005.
   PubMed Web of Science ®Google Scholar
• Axelrad TW, Deo DD, Ottino P, Van Kirk J, Bazan NG, Bazan HE, Hunt JD. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. FASEB J. 2004;18(3):568–70. doi:10.1096/fj.03-0479fje.
   PubMed Web of Science ®Google Scholar
• Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood. 2007;109(9):4055–63. doi:10.1182/blood-2006-10-051060.
   PubMed Web of Science ®Google Scholar
• Fabunmi RP, Sukhova GK, Sugiyama S, Libby P. Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. Circ Res. 1998;83(3):270–78. doi:10.1161/01.RES.83.3.270.
   PubMed Web of Science ®Google Scholar
• Schollhorn L, Bock F, Cursiefen C. Thrombospondin-1 as a regulator of corneal inflammation and lymphangiogenesis: effects on dry eye disease and corneal graft immunology. J Ocul Pharmacol Ther. 2015;31(7):376–85. doi:10.1089/jop.2015.0020.
   PubMed Web of Science ®Google Scholar
• Masli S, Sheibani N, Cursiefen C, Zieske J. Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation. Curr Eye Res. 2014;39:759–74.
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Maruyama K, Bock F, Saban D, Sadrai Z, Lawler J, Dana R, Masli S. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med. 2011;208:1083–92.
   PubMed Web of Science ®Google Scholar
• Young TL, Scavello GS, Paluru PC, Choi JD, Rappaport EF, Rada JA. Microarray analysis of gene expression in human donor sclera. Mol Vis. 2004;10:163–76.
   PubMed Web of Science ®Google Scholar
• Young TL, Hawthorne F, Feng S, Luo X, St Germain E, Wang M, Metlapally R. Whole genome expression profiling of normal human fetal and adult ocular tissues. Exp Eye Res. 2013;116:265–78.
   PubMed Web of Science ®Google Scholar
• Seko Y, Azuma N, Takahashi Y, Makino H, Morito T, Muneta T, Matsumoto K, Saito H, Sekiya I, Umezawa A. Human sclera maintains common characteristics with cartilage throughout evolution. PLoS One. 2008;3:e3709.
   PubMed Web of Science ®Google Scholar
• Sokolov MV, Panyutin IG, Neumann RD. Whole-genome gene expression profiling reveals the major role of nitric oxide in mediating the cellular transcriptional response to ionizing radiation in normal human fibroblasts. Genomics. 2012;100:277–81.
   PubMed Web of Science ®Google Scholar
• Metlapally R, Gonzalez P, Hawthorne FA, Tran-Viet KN, Wildsoet CF, Young TL. Scleral micro-RNA signatures in adult and fetal eyes. PLoS One. 2013;8:e78984.
   PubMed Web of Science ®Google Scholar
• Tkatchenko AV, Luo X, Tkatchenko TV, Vaz C, Tanavde VM, Maurer-Stroh S, Zauscher S, Gonzalez P, Young TL. Large-scale microRNA expression profiling identifies putative retinal miRNA-mRNA signaling pathways underlying form-deprivation myopia in mice. PLoS One. 2016;11:e0162541.
   PubMed Web of Science ®Google Scholar